This globally operating pharmaceutical company focuses on developing and manufacturing a broad range of affordable medications. They specialize in both prescription and over-the-counter drugs, including oncology treatments, antibacterials, injectables (both specialty and large volume), ophthalmic products, dermatological preparations, and veterinary pharmaceuticals. Their product portfolio also includes unique niche drugs and orphan products, showcasing their commitment to addressing diverse medical needs. The company boasts state-of-the-art manufacturing facilities located across several regions, adhering to strict quality standards recognized by international regulatory bodies like the WHO GMP, US FDA, and MCC. Their extensive global reach spans over 45 countries in Asia, Africa, Latin America, CIS, Europe, Australia, and the Pacific Ocean. The company's focus on research and development, coupled with its global manufacturing capabilities and commitment to quality, positions them as a key player in the international pharmaceutical market.

Established in 1996, this Manufacturer is a WHO-GMP and ISO-certified CTD dossier owner and manufacturer, employing between 101 to 250 professionals. As a GMP manufacturer, it operates dedicated production lines for cephalosporins, beta-lactam, penam, general dry powder injections, ophthalmic solutions, and liquid injectables in ampoules, vials, pre-filled syringes, and dental cartridges. With a portfolio exceeding 250 formulations, the Manufacturer exports products to over 44 countries and regions worldwide. As a CTD dossier owner and manufacturer, it upholds stringent GMP standards across all operations. Committed to global health, this GMP manufacturer continues to expand its presence in regulated markets.